Save the date for
The investor conference for innovatorsJanuary 13–15, 2025 Sapan ShahCEO at Glyscend TherapeuticsSpeaker
Agenda Sessions
Metabolic Syndrome: Therapeutic Advances to Short Circuit Debilitating Disease
, 08:00View Session